Can Gilead Produce A Beat In Upcoming Q2 Earnings?


Gilead (NYSE:GILD) announces earnings in 4 days time and the jury is still out as to where this stock will go in the short term. Its HVC sales are under pressure and although it holds a strong balance sheet, most of its cash flow has been ploughed into share buybacks recently which haven’t really moved the share price. Gilead needs to convince the market that it wont lose any more market share in the HVC market. Can it pull it off?

This entry was posted in Stock Picks and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.